article · New Journal of Chemistry
A comprehensive in silico strategy integrating 3D-QSAR, ANN, docking, ADMET, MD simulations and retrosynthesis led to the identification of a new drug candidate (L5) as a promising aromatase inhibitor for breast cancer.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1039/d5nj02417j
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
